Exploring the joint potential of inflammation, immunity, and receptor-based biomarkers for evaluating ME/CFS progression

Exploring the joint potential of inflammation, immunity, and receptor-based biomarkers for evaluating ME/CFS progression

BackgroundMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating chronic condition with no identified diagnostic biomarkers to date. Its prevalence is as high as 0.89% according to metastudies, with a quarter of patients bed- or home-bound, which presents a serious public heal...

Full description

Bibliographic Details
Main Authors: Uldis Berkis, Simons Svirskis, Angelika Krumina, Sabine Gravelsina, Anda Vilmane, Diana Araja, Zaiga Nora-Krukle, Modra Murovska
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Immunology
Subjects:
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
immunome
inflammatome
artificial intelligence (AI) supported diagnosis
prognostic and therapy assessment biomarkers
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1294758/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1294758/full

Similar Items